Barinthus Biotherapeutics (BRNS) Proxy Filing summary

Executive summary

• Annual meeting scheduled for June 10, 2025, with voting open until June 3, 2025.

• Shareholders can access proxy materials online or request paper/email copies by May 19, 2025.

• Meeting will be held at Goodwin Procter (UK) LLP, London, with options for remote or in-person voting.

Voting matters and shareholder proposals

• Proposals include re-election of Pierre A. Morgon and Joseph C. Scheeren as directors.

• Appointment and ratification of PricewaterhouseCoopers LLP as statutory auditors and independent registered public accounting firm for 2025.

• Authorization for the Audit Committee to determine auditors' remuneration for 2025.

• Approval of directors' remuneration policy and advisory approval of the directors' compensation report for 2024.

• Receipt of U.K. statutory annual accounts and reports for 2024, with no dividend recommended for the year.

Board of directors and corporate governance

• Directors up for re-election are retiring by rotation in accordance with the Articles of Association.